Back to Treasuries
🇺🇸
LIXTE Biotechnology
Company - US
About LIXTE Biotechnology
LIXTE Biotechnology holds BTC and ETH as part of its corporate treasury strategy, representing a significant digital asset position.
Holdings & Financials
Total Holdings: $1.33M
Cost Basis: -
Unrealized Gain: -
Premium to NAV: -